In vitro effect of subminimal inhibitory concentrations of antibiotics on the biofilm formation ability of Acinetobacter baumannii clinical isolates

References

• Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73(4):355–63.10.1016/j.jhin.2009.03.032
   PubMed Web of Science ®Google Scholar
• Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents. 2010;35(3):219–26.10.1016/j.ijantimicag.2009.10.024
   PubMed Web of Science ®Google Scholar
• Kaliterna V, Goic-Barisic I. The ability of biofilm formation in clinical isolates of Acinetobacter baumannii belonging to two different European clones causing outbreaks in the Split University Hospital, Croatia. J Chemother. 2013;25(1):60–2 . Epub 2013/02/26.10.1179/1973947812Y.0000000052
   PubMed Web of Science ®Google Scholar
• Roca I, Espinal P, Vila-Farres X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol. 2012;3:148.
   PubMed Web of Science ®Google Scholar
• Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014;37(2):119–27.
   PubMed Web of Science ®Google Scholar
• Martí S, Rodríguez-Baño J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H, et al. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes. 2011;4:5.10.1186/1756-0500-4-5
   PubMedGoogle Scholar
• Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:39.10.1186/1471-2334-13-47
   PubMed Web of Science ®Google Scholar
• Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005;436(7054):1171–5.10.1038/nature03912
   PubMed Web of Science ®Google Scholar
• Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34(9):737–51.10.5301/ijao.5000027
   PubMed Web of Science ®Google Scholar
• Nucleo E, Steffanoni L, Fugazza G, Migliavacca R, Giacobone E, Navarra A, et al. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 2009;9:270.10.1186/1471-2180-9-270
   PubMed Web of Science ®Google Scholar
• Fonseca AP, Extremina C, Fonseca AF, Sousa JC. Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa. J Med Microbiol. 2004;53(9):903–10.10.1099/jmm.0.45637-0
   PubMed Web of Science ®Google Scholar
• King LB, Swiatlo E, Swiatlo A, McDaniel LS. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol. 2009;55(3):414–21.10.1111/j.1574-695X.2009.00538.x
   PubMedGoogle Scholar
• Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Ćirković I, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115(8):891–9.10.1111/apm.2007.115.issue-8
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Seventh Edition. CLSI document M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2006. ISBN 1-56238-587-9.
   Google Scholar
• Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005;43(9):4328–35.10.1128/JCM.43.9.4328-4335.2005
   PubMed Web of Science ®Google Scholar
• Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4(3):273–8.10.2217/fmb.09.5
   PubMed Web of Science ®Google Scholar
• Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I, et al. Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci. 2017;18(5): pii:E1077. Epub 2017/05/18.
   Web of Science ®Google Scholar
• Ryu SY, Baek WK, Kim HA. Association of biofilm production with colonization among clinical isolates of Acinetobacter baumannii. The Korean J Int Med. 2017;32(2):345–51. Epub 2016/09/23.10.3904/kjim.2015.287
   PubMed Web of Science ®Google Scholar
• Rodríguez-Baño J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón J, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008;14(3):276–8.10.1111/j.1469-0691.2007.01916.x
   PubMed Web of Science ®Google Scholar
• Vijayakumar S, Rajenderan S, Laishram S, Anandan S, Balaji V, Biswas I. Biofilm formation and motility depend on the nature of the Acinetobacter baumannii clinical isolates. Front Public Health. 2016;4:105. eCollection 2016.​ Epub 2016/06/03. Available from: http://journal.frontiersin.org/journal/public-health/section/infectious-diseases#about
   PubMed Web of Science ®Google Scholar
• Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2008;26(4):333–7.
   PubMed Web of Science ®Google Scholar
• Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9):1061–72.10.2217/fmb.12.76
   PubMed Web of Science ®Google Scholar
• Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med. 2013;17(4):214–8.
   PubMedGoogle Scholar
• Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis. 2007;45(5):594–8.10.1086/520658
   PubMed Web of Science ®Google Scholar
• Perez LR. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J Chemother. 2015;27(1):13–6.10.1179/1973947813Y.0000000159
   PubMed Web of Science ®Google Scholar
• Qi L, Li H, Zhang C, Liang B, Li J, Wang L, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol. 2016;7:483. eCollection 2016. Available from: http://journal.frontiersin.org/article/10.3389/fmicb.2016.00483/full
   PubMed Web of Science ®Google Scholar
• Wroblewska MM, Sawicka-Grzelak A, Marchel H, Luczak M, Sivan A. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals. FEMS Immunol Med Microbiol. 2008;53(1):140–4.10.1111/fim.2008.53.issue-1
   PubMedGoogle Scholar
• de Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, Bloemberg G, et al. Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS ONE. 2010;5(5):e10732.10.1371/journal.pone.0010732
   PubMed Web of Science ®Google Scholar
• Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, Balikci E, et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit: Int Med J Exp Clin Res. 2004;10(6): BR180–4.
   Google Scholar
• Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol. 2011;62(3):328–38.10.1111/j.1574-695X.2011.00818.x
   PubMedGoogle Scholar
• Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, et al. Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57(8):3883–8.10.1128/AAC.00457-13
   PubMed Web of Science ®Google Scholar
• Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int J Antimicrob Agents. 2006;27(3):224–8.10.1016/j.ijantimicag.2005.10.012
   PubMed Web of Science ®Google Scholar
• Liu B, Liu Y, Di X, Zhang X, Wang R, Bai Y, et al. Colistin and anti-gram-positive bacterial agents against Acinetobacter baumannii. Rev Soc Bras Med Trop. 2014;47(4):451–6.10.1590/0037-8682-0081-2014
   PubMed Web of Science ®Google Scholar
• Bedenić B, Beader N, Godič-Torkar K, Prahin E, Mihaljević L, Ćačić M, et al. Postantibiotic effect of colistin alone and combined with vancomycin or meropenem against Acinetobacter spp. with well defined resistance mechanisms. J Chemother. 2016;28(5):375–82.10.1179/1973947815Y.0000000062
   PubMed Web of Science ®Google Scholar
• Yang H, Chen G, Hu L, Liu Y, Cheng J, Li H, et al. In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. Int J Antimicrob Agents. 2015;45(2):188–91.10.1016/j.ijantimicag.2014.10.012
   PubMed Web of Science ®Google Scholar
• Wang Y, Bao W, Guo N, Chen H, Cheng W, Jin K, et al. Antimicrobial activity of the imipenem/rifampicin combination against clinical isolates of Acinetobacter baumannii grown in planktonic and biofilm cultures. World J Microbiol Biotechnol. 2014;30(12):3015–25.10.1007/s11274-014-1728-7
   PubMed Web of Science ®Google Scholar